Co-encapsulated resveratrol and quercetin in chitosan and peg modified chitosan nanoparticles: For efficient intra ocular pressure reduction

International Journal of Biological Macromolecules

Volumn 104, Issue , 2017, Pages 1837-1845

  Natesan, Subramanian ^a   Pandian, Saravanakumar ^a   Ponnusamy, Chandrasekar ^a   Palanichamy, Rajaguru ^a   Muthusamy, Sivakumar ^a   Kandasamy, Ruckmani ^a  

^a ANNA UNIVERSITY   (India)

Author keywords

Chitosan; Quercetin; Resveratrol

Indexed keywords

CHITOSAN NANOPARTICLE; MACROGOL; QUERCETIN; RESVERATROL; TRIPOLYPHOSPHATE; ANTIOXIDANT; CHITOSAN; DRUG CARRIER; MACROGOL DERIVATIVE; NANOPARTICLE; STILBENE DERIVATIVE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL MEMBRANE; CORNEA CELL; CRYSTAL STRUCTURE; DRUG DELIVERY SYSTEM; DRUG EFFECT; DRUG FORMULATION; DRUG POTENTIATION; DRUG RELEASE; FREE RADICAL SCAVENGING ASSAY; GELATION; GLAUCOMA; INTRAOCULAR PRESSURE; LOADING DRUG DOSE; MEMBRANE TRANSPORT; NANOENCAPSULATION; NONHUMAN; PARTICLE SIZE; SYNTHESIS; X RAY POWDER DIFFRACTION; ANIMAL; CHEMISTRY; CHICKEN; INFRARED SPECTROSCOPY; LEPORIDAE; OSMOLARITY; PH; ULTRASTRUCTURE;

ANIMALS; ANTIOXIDANTS; CHICKENS; CHITOSAN; DRUG CARRIERS; DRUG COMPOUNDING; DRUG LIBERATION; HYDROGEN-ION CONCENTRATION; INTRAOCULAR PRESSURE; NANOPARTICLES; OSMOLAR CONCENTRATION; PARTICLE SIZE; POLYETHYLENE GLYCOLS; QUERCETIN; RABBITS; SPECTROSCOPY, FOURIER TRANSFORM INFRARED; STILBENES;

EID: 85019167691     PISSN: 01418130     EISSN: 18790003     Source Type: Journal    
DOI: 10.1016/j.ijbiomac.2017.04.117     Document Type: Article

References (35)

1. Susanna, R. Jr, De Moraes, C.G., Cioffi, G.A., Ritch, R., Why do people (Still) go blind from glaucoma?. Transl. Vis. Sci. Technol., 4, 2015, 1.
2. Tanito, M., Kaidzu, S., Takai, Y., Ohira, A., Correlation between systemic oxidative stress and intraocular pressure level. PLoS One, 17, 2015 10(7).
3. Rahman, K., Studies on free radicals, antioxidants and co-factors. Clin. Interv. Aging 2 (2007), 219–236.
4. Tanito, M., Kaidzu, S., Takai, Y., Ohira, A., Status of systemic oxidative stresses in patients with primary open-angle glaucoma and pseudoexfoliation syndrome. PLoS One, 7, 2012, 11.
5. Erdurmus, M., Yagcı, R., Atis, O., Karadag, R., Akbas, A., Hepsen, I.F., Antioxidant status and oxidative stress in primary open angle glaucoma and pseudoexfoliative glaucoma. Curr. Eye Res. 36 (2011), 713–718.
6. Hooper, L., Cassidy, A., A review of the health care potential of bioactive compounds. J. Sci. Food Agric. 86 (2006), 1805–1813.
7. Pandey, K.B., Rizvi, S.I., Plant polyphenols as dietary antioxidants in human health and disease. Oxid. Med. Cell Longev. 2 (2009), 270–278.
8. Anisimova, N.Y., Kiselevsky, M.V., Sosnov, A.V., Sadovnikov, S.V., Stankov, I.N., Gakh, A.A., Trans-, cis-, and dihydro-resveratrol: a comparative study. Chem. Cent. J., 20, 2011, 88.
9. Bola, C., Bartlett, H., Eperjesi, F., Resveratrol and the eye: activity and molecular mechanisms. Graefes Arch. Clin. Exp. Ophthalmol. 252 (2014), 699–713.
10. Mimura, T., Kaji, Y., Noma, H., Funatsu, H., Okamoto, S., The role of SIRT1 in ocular aging. Exp. Eye Res. 116 (2013), 17–26.
11. Curcio, M., Cirillo, G., Parisi, O.I., Iemma, F., Spizzirri, U.G., Altimari, I., Picci, N., Puoci, F., Poly(2-hydroxyethyl methacrylate)-quercetin conjugate as biomaterial in ophthalmology: an ab initio study. J. Funct. Biomater. 27 (2011), 1–17.
12. Zhuang, P., Shen, Y., Lin, B.Q., Zhang, W.Y., Chiou, G.C., Effect of quercetin on formation of choroidal neovascularization (CNV) in age-related macular degeneration (AMD). Eye Sci. 26 (2011), 23–29.
13. Adelli, G.R., Srirangam, R., Majumdar, S., Phytochemicals in ocular health: therapeutic potential and delivery challenges. World J. Pharmacol. 9 (2013), 18–34.
14. Katas, H., Alpar, H.O., Development and characterisation of chitosan nanoparticles for siRNA delivery. J. Control. Release 10 (2006), 216–225.
15. Casettari, L., Vllasaliu, D., Castagnino, E., Stolnik, S., Howdle, S., Illu, L., PEGylated chitosan derivatives: synthesis, characterizations and pharmaceutical applications. Prog. Polym. Sci. 37 (2012), 659–685.
16. Bhattarai, N., Ramay, H.R., Gunn, J., Matsen, F.A., Zhang, M., PEG-grafted chitosan as an injectable thermosensitive hydrogel for sustained protein release. J. Control. Release 18 (2005), 609–624.
17. Saravanakumar, P., Vinoth, J., Chandrasekar, P., Subramanian, N., RES-loaded pegylated CS NPs: for efficient ocular delivery. IET Nanobiotechnol. 11 (2017), 32–39.
18. Brianna, C., Lisa, J.C., Deepa, A.R., Adam, W.G.A., Combinatorial resveratrol and quercetin polymeric micelles mitigate doxorubicin induced cardiotoxicity in vitro and in vivo. J. Control. Release 213 (2015), 128–133.
19. Abdallah, H.M., Al-Abd, A.M., El-Dine, R.S., El-Halawanya, A.M., P-glycoprotein inhibitors of natural origin as potential tumor chemo-sensitizers: a review. J. Adv. Res. 6 (2015), 45–62.
20. Billa, C.N., Roberts, C.J., Burley, J.C., Manickam, S., Curcumin-containing chitosan nanoparticles as a potential mucoadhesive delivery system to the colon. Pharm. Dev. Technol. 18 (2013), 591–599.
21. Hippalgaonkar, K., Adelli, G.R., Hippalgaonkar, K., Repka, M.A., Majumdar, S., Indomethacin-loaded solid lipid nanoparticles for ocular delivery: development, characterization, and in-vitro evaluation. J. Ocul. Pharmacol. Ther. 29 (2013), 216–228.
22. Biasutto, L., Marotta, E., Garbisa, S., Zoratti, M., Paradisi, C., Determination of quercetin and resveratrol in whole blood implications for bioavailability studies. Molecules 0 (2010), 6570–6579.
23. Sahoo, N.G., Kakran, M., Shaal, L.A., Li, L., Muller, R.H., Pal, M., Tan, L.P., Preparation and characterization of quercetin nanocrystals. J. Pharm. Sci. 100 (2011), 2379–2390.
24. Malhotra, M., Lane, C., Tomaro-Duchesneau, C., Saha, S., Prakash, S., A novel method for synthesizing PEGylated chitosan nanoparticles: strategy, preparation and in vitro analysis. Int. J. Nanomed. 6 (2011), 485–494.
25. Wu, Y., Yang, W., Wang, C., Hu, J., Fu, S., Chitosan nanoparticles as a novel delivery system for ammonium glycyrrhizinate. Int. J. Pharm. 13 (2005), 235–245.
26. Rathore, M.S., Majumdar, D.K., Effect of formulation factors on in-vitro transcorneal permeation of gatifloxacin from aqueous drops. AAPS Pharm. Sci. Tech., 7, 2006, 57.
27. Quellec, P., Gref, R., Perrin, L., Dellacherie, E., Sommer, F., Verbavatz, J.M., Aloson, M.J., Protein encapsulation within polyethylene glycol-coated nanospheres. Physicochemical characterization. J. Biomed. Mater. Res. 42 (1998), 45–54.
28. Natarajan, V., Saravanakumar, P., Madhan, B., Collagen adsorption on quercetin loaded polycaprolactone microspheres: approach for stealth implant. Int. J. Biol. Macromol. 1 (2012), 1091–1094.
29. Dai, J., Mumper, R.J., Plant phenolics: extraction, analysis and their antioxidant and anticancer properties. Molecules 21 (2010), 7313–7352.
30. Mendes, J.B., Riekes, M.K., de Oliveira, V.M., Michel, M.D., Stulzer, H.K., Khalil, N.M., Zawadzki, S.F., Mainardes, R.M., Farago, P.V., PHBV/PCL microparticles for controlled release of resveratrol: physicochemical characterization, antioxidant potential, and effect on hemolysis of human erythrocytes. Sci. World J. 2012 (2012), 5429–5437.
31. Parveen, S., Sahoo, S.K., Long circulating chitosan/PEG blended PLGA nanoparticle for tumor drug delivery. Eur. J. Pharmacol. 30 (2011), 372–383.
32. Q. Ashton Acton, Issues in ophthalmology and optometry research and practice: 2013 Edition, Scholarly edition, Atlanda, Georgea.
33. Ganie, S.A., Haq, E., Masood, A., Hamid, A., Zargar, M.A., Antioxidant and protective effect of ethyl acetate extract of podophyllumhexandrum rhizome on carbon tetrachloride induced rat liver injury. Evid. Based Complement. Altern. Med., 2011, 2011, 238020.
34. Shi, S., Zhang, Z., Luo, Z., Yu, J., Liang, R., Li, X., Chen, H., Chitosan grafted methoxy poly (ethylene glycol)-poly (ε-caprolactone) nanosuspension for ocular delivery of hydrophobic diclofenac. Sci. Rep., 5, 2015, 11337.
35. Kaskoos, R.A., Investigation of moxifloxacin loaded chitosan–dextran nanoparticles for topical instillation into eye: in-vitro and ex-vivo evaluation. Int. J. Pharm. Investig. 4 (2014), 164–173.